
A new breakthrough drug offers hope for targeting the root cause of narcolepsy
A new drug called Orzeyful, developed by Takeda and approved by the US FDA, targets the underlying biological cause of…
Uplifting stories of progress, kindness and possibility.

A new drug called Orzeyful, developed by Takeda and approved by the US FDA, targets the underlying biological cause of…